OverviewSuggest Edit

The UK’s first dedicated synthetic biology company with a world leading platform of technologies for the rapid engineering and optimisation of novel biological production systems. A spin out of University College London, Synthace is already producing high-value research and development products for the pharmaceutical, agrochemical and fine chemicals industry. Synthace bioengineering is enabled by a tight integration of computational modelling and big data analysis with wet lab experimental design and validation, and novel molecular biology tools. While Synthace bioengineering is broadly applicable across multiple industry sectors, the company is focused towards applications in the production of specialty chemicals.
TypePrivate
Founded2011
HQLondon, GB
Websitesynthace.com

Latest Updates

Employees (est.) (Jun 2021)76(+6%)
Revenue (FY, 2013)£581
Cybersecurity ratingBMore

Key People/Management at Synthace

Bob Wiederhold

Bob Wiederhold

Chairman
Tim Fell

Tim Fell

Chief Executive Officer, Director
Christopher Grant Ward

Christopher Grant Ward

Co-Founder
Susan Shiff

Susan Shiff

Non-Executive Director
Isabel Fox

Isabel Fox

Non-Executive Director
Patrick Zhang

Patrick Zhang

Non-Executive Director
Show more

Synthace Office Locations

Synthace has offices in London and Cambridge
London, GB (HQ)
195 Wood Ln, Shepherd's Bush
Cambridge, MA, US
101 Main St
Show all (2)

Synthace Financials and Metrics

Summary Metrics

Founding Date

2011

Synthace total Funding

$41.8 m

Synthace latest funding size

$25.6 m

Time since last funding

3 years ago

Synthace investors

Synthace's latest funding round in December 2018 was reported to be $25.6 m. In total, Synthace has raised $41.8 m
Show all financial metrics

Synthace Revenue

Synthace's revenue was reported to be £581 in FY, 2013
GBP

Revenue (FY, 2013)

581.0

Net income (FY, 2013)

(361.6k)

EBITDA (FY, 2013)

(356.8k)

EBIT (FY, 2013)

(361.6k)

Cash (31-May-2018)

4.9m
GBPFY, 2012FY, 2013

Revenue

581.0

Operating expense total

362.2k

EBITDA

(356.8k)

EBITDA margin, %

(61413%)
GBPFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

351.4k103.4k321.7k1.5m245.0k224.3k4.9m

Accounts Receivable

240.0159.9k73.2k9.6k46.6k107.7k

Current Assets

358.1k150.1k481.6k1.6m646.8k883.2k5.8m

PP&E

1.6k14.8k298.8k200.5k265.6k186.8k235.7k
GBPFY, 2012FY, 2013

Net Income

(43.1k)(361.6k)
GBPFY, 2012

Financial Leverage

1 x
Show all financial metrics

Synthace Cybersecurity Score

Cybersecurity ratingPremium dataset

B

82/100

SecurityScorecard logo

Synthace Online and Social Media Presence

Embed Graph

Synthace News and Updates

Synthace raises $25.6 million to automate bio labs with software

Synthace, a U.K. startup developing an operating system to automate lab work, announced that it has raised $25.6 million in a Series B round.

Synthace reels in $9.6 mln Series A

London-based Synthace, the developer of the Antha operating system for biology, has raised $9.6 million in Series A funding. The investors included White Cloud Capital, Amadeus Capital Partners, Eleven Two Capital, Sofinnova Partners, SOSV and Bioeconomy Capital.

Synthace Blogs

Designing for Biotech: Insights in Product Design (Part 1)

Designing for Biotech: Insights in Product Design (Part 1) Filter Search by keyword Browse by category Article Bioprocessing Gene Therapy Lab of the Future News Our People Tags AI Bioprocessing Conference Customer Success Data Demo Design of Experiments (DOE) DNA Assembly ELISA Engineering Gene Ther…

Rapid Automation and Analysis of a Competitive ELISA Kit with Antha

Rapid Automation and Analysis of a Competitive ELISA Kit with Antha Read the full report × Key findings.... Rapid adaptation of an automated sandwich ELISA protocol to a competitive format in 15 min using our Antha® software. Antha integrated three independent devices into a single automated workcel…

Veteran Technology Executive Joins Synthace to Accelerate Its Mission to Revolutionize the Life Science Research Market

Veteran Technology Executive Joins Synthace to Accelerate Its Mission to Revolutionize the Life Science Research Market Filter Search by keyword Browse by category Article Bioprocessing Gene Therapy Lab of the Future News Our People Tags AI Bioprocessing Conference Customer Success Data Demo Design …

Enhance Your Optimizations with Flexible, Automated Design of Experiments (DOE)

Enhance Your Optimizations with Flexible, Automated Design of Experiments (DOE) Design of Experiments (DOE) is a powerful statistical approach to exploring the design space and optimizing experiments. In biology, its usage is facilitated by technique familiarity and statistical experience, but also …

People of Synthace: Sarah James, PhD – Senior Technical Specialist

People of Synthace: Sarah James, PhD – Senior Technical Specialist Filter Search by keyword Browse by category Article Bioprocessing Gene Therapy Lab of the Future News Our People Tags AI Bioprocessing Conference Customer Success Data Demo Design of Experiments (DOE) DNA Assembly ELISA Engineering G…

People of Synthace: Matthew Gregg – Software Developer

People of Synthace: Matthew Gregg – Software Developer Filter Search by keyword Browse by category Article Bioprocessing Gene Therapy Lab of the Future News Our People Tags AI Bioprocessing Conference Customer Success Data Demo Design of Experiments (DOE) DNA Assembly ELISA Engineering Gene Therapy …
Show more

Synthace Frequently Asked Questions

  • When was Synthace founded?

    Synthace was founded in 2011.

  • Who are Synthace key executives?

    Synthace's key executives are Bob Wiederhold, Tim Fell and Christopher Grant Ward.

  • How many employees does Synthace have?

    Synthace has 76 employees.

  • What is Synthace revenue?

    Latest Synthace annual revenue is £581.

  • What is Synthace revenue per employee?

    Latest Synthace revenue per employee is £8.

  • Who are Synthace competitors?

    Competitors of Synthace include International Stem Cell Corporation, IDEX Health & Science and The Biomedical Engineering Society.

  • Where is Synthace headquarters?

    Synthace headquarters is located at 195 Wood Ln, Shepherd's Bush, London.

  • Where are Synthace offices?

    Synthace has offices in London and Cambridge.

  • How many offices does Synthace have?

    Synthace has 2 offices.